Therapeutics – Medgate Today

Granules India enters the high growing peptide segment and CDMO business by acquiring Senn Chemicals AG

February 26, 2025

8:03 am

Granules India Limited (BSE: 532482, NSE: GRANULES) today announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. Senn develops and manufactures, Peptides and Peptides based applications for its global customers, providing contract research, development, and manufacturing services.

POST TAGS:

Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT

November 2, 2023

8:16 am

News Update

admin

Study Synopsis In patients classified as HBR, there was a significant reduction in the primary endpoint (p=0.043) when comparing physiology-guided complete revascularization to the culprit-only strategy. The study was conducted across 34 participating sites spanning Italy, Spain, and Poland covering 1445 patients from July

POST TAGS:

designed Dr Krishna Sudhir Dr Simone Biscaglia Ferrara heart-attack Hospital &Medical Medical officer NSTEMI Physiology Sahajanand Medical Technologies SMT Supraflex TCT Therapeutics

Granules India enters the high growing peptide segment and CDMO business by acquiring Senn Chemicals AG

POST TAGS:

Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT

POST TAGS:

FIND US

ADDRESS

FOLLOW US ON SOCIAL MEDIA